Ann Surg Oncol
- ROSHAN A, Shah B, Anderson KD, Murphy S, et al
ASO Visual Abstract: Robot-Assisted Pelvic Dissection for Enlarged Lymph Nodes in
Melanoma Improves Recovery with Equivalent Oncological Outcomes to Open Pelvic
Dissection.
Ann Surg Oncol. 2024 Jan 22. doi: 10.1245/s10434-024-14920.
Br J Cancer
- ZAKKAK N, Barclay ME, Swann R, McPhail S, et al
The presenting symptom signatures of incident cancer: evidence from the English
2018 National Cancer Diagnosis Audit.
Br J Cancer. 2024;130:297-307.
Br J Dermatol
-
Risk factors for developing a new primary melanoma in people with a melanoma.
Br J Dermatol. 2024;190:e15.
-
Genes associated with nodular melanoma.
Br J Dermatol. 2024;190:e18.
Cancer Lett
- LIU C, Cheng X, Han K, Hong L, et al
A novel molecular subtyping based on multi-omics analysis for prognosis
predicting in colorectal melanoma: A 16-year prospective multicentric study.
Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
Clin Cancer Res
- ANDERSON TM, Chang BH, Huang AC, Xu X, et al
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment
Response in Patients with Advanced Melanoma.
Clin Cancer Res. 2024 Jan 24:OF1-OF10. doi: 10.1158/1078-0432.CCR-23-2390.
J Am Acad Dermatol
- CHOI ME, Jung JM, Kim DH, Won CH, et al
Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to
Non-Acral Melanoma and its Prognostic Significance.
J Am Acad Dermatol. 2024 Jan 23:S0190-9622(24)00103.
- TATE JA, Matsumoto A, Greif C, Lim J, et al
Excision Margins for Melanoma in Situ on the Head and Neck - A Single-Center
10-year Retrospective Review of Treatment with Mohs Micrographic Surgery.
J Am Acad Dermatol. 2024 Jan 20:S0190-9622(24)00102.
- SHIFAI N, van Doorn R, Malvehy J, Sangers T, et al
Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.
J Am Acad Dermatol. 2024 Jan 18:S0190-9622(24)00076.
Lancet
- WEBER JS, Carlino MS, Khattak A, Meniawy T, et al
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus
pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase
2b study.
Lancet. 2024 Jan 18:S0140-6736(23)02268-7. doi: 10.1016/S0140-6736(23)02268.
Melanoma Res
- DAVIDSON TM, Hieken TJ, Glasgow AE, Habermann EB, et al
Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020.
Melanoma Res. 2024 Jan 23. doi: 10.1097/CMR.0000000000000953.
Nat Med
- O'LEARY K
Personalized mRNA vaccine boosts melanoma immunotherapy.
Nat Med. 2024 Jan 25. doi: 10.1038/d41591-024-00006.
Oncogene
- CANNON AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, et al
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and
immune checkpoints.
Oncogene. 2024 Jan 19. doi: 10.1038/s41388-024-02947.
PLoS One
- LIU Y, Wang S, Wei S, Qiu X, et al
The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration
of melanoma cells via the JMJD2C/ALKBH5 axis.
PLoS One. 2024;19:e0290986.
Proc Natl Acad Sci U S A
- BANUELOS A, Zhang A, Berouti H, Baez M, et al
CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell
clearance.
Proc Natl Acad Sci U S A. 2024;121:e2318534121.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016